Galapagos (GLPG) Downgraded by BidaskClub
Galapagos (NASDAQ:GLPG) was downgraded by research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Friday.
Several other analysts have also recently weighed in on the company. BTIG Research reissued a “buy” rating and set a $118.00 price target on shares of Galapagos in a report on Thursday, February 8th. ValuEngine raised Galapagos from a “sell” rating to a “hold” rating in a report on Friday, February 2nd. Finally, Zacks Investment Research cut Galapagos from a “hold” rating to a “strong sell” rating in a report on Thursday, January 25th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $111.00.
Shares of Galapagos (NASDAQ GLPG) opened at $102.67 on Friday. Galapagos has a fifty-two week low of $71.93 and a fifty-two week high of $121.09.
ILLEGAL ACTIVITY WARNING: This story was published by Daily Political and is the property of of Daily Political. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://www.dailypolitical.com/2018/03/04/galapagos-glpg-downgraded-by-bidaskclub.html.
Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.
Receive News & Ratings for Galapagos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galapagos and related companies with MarketBeat.com's FREE daily email newsletter.